Cachet Pharmaceutical Co., Ltd. (002462.SZ)
CNY 13.73
(-0.94%)
CNY 13.73
(-0.94%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 175.94 Million CNY | -15.72% |
| 2022 | 208.75 Million CNY | -8.94% |
| 2021 | 229.24 Million CNY | 30.21% |
| 2020 | 176.05 Million CNY | 2739.83% |
| 2019 | 6.19 Million CNY | -99.17% |
| 2018 | 746 Million CNY | 0.0% |
| 2017 | 746 Million CNY | 12333.33% |
| 2016 | 6 Million CNY | 0.0% |
| 2015 | - CNY | 0.0% |
| 2014 | - CNY | 0.0% |
| 2013 | - CNY | 0.0% |
| 2012 | - CNY | 0.0% |
| 2011 | - CNY | 0.0% |
| 2010 | - CNY | 0.0% |
| 2009 | - CNY | 0.0% |
| 2008 | - CNY | 0.0% |
| 2007 | - CNY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 185.13 Million CNY | 0.0% |
| 2024 Q3 | - CNY | 0.0% |
| 2024 Q2 | 169.52 Million CNY | 0.0% |
| 2023 Q4 | 175.94 Million CNY | -14.78% |
| 2023 Q2 | 213.54 Million CNY | -3.67% |
| 2023 FY | 175.94 Million CNY | -15.72% |
| 2023 Q3 | 206.46 Million CNY | -3.32% |
| 2023 Q1 | 221.69 Million CNY | 6.2% |
| 2022 Q2 | 239.13 Million CNY | -1.02% |
| 2022 Q3 | 230.6 Million CNY | -3.57% |
| 2022 FY | 208.75 Million CNY | -8.94% |
| 2022 Q4 | 208.75 Million CNY | -9.47% |
| 2022 Q1 | 241.6 Million CNY | 5.39% |
| 2021 Q3 | 213.28 Million CNY | -0.54% |
| 2021 Q4 | 229.24 Million CNY | 7.48% |
| 2021 Q1 | 198.3 Million CNY | 12.64% |
| 2021 FY | 229.24 Million CNY | 30.21% |
| 2021 Q2 | 214.43 Million CNY | 8.14% |
| 2020 Q3 | 197.23 Million CNY | 4.18% |
| 2020 Q1 | 6 Million CNY | -3.22% |
| 2020 Q4 | 176.05 Million CNY | -10.74% |
| 2020 Q2 | 189.32 Million CNY | 3055.37% |
| 2020 FY | 176.05 Million CNY | 2739.83% |
| 2019 Q3 | 6 Million CNY | -99.2% |
| 2019 Q1 | 746 Million CNY | 0.0% |
| 2019 Q4 | 6.19 Million CNY | 3.33% |
| 2019 FY | 6.19 Million CNY | -99.17% |
| 2019 Q2 | 746 Million CNY | 0.0% |
| 2018 Q2 | 746 Million CNY | 0.0% |
| 2018 Q1 | 746 Million CNY | 0.0% |
| 2018 FY | 746 Million CNY | 0.0% |
| 2018 Q3 | 746 Million CNY | 0.0% |
| 2018 Q4 | 746 Million CNY | 0.0% |
| 2017 Q2 | 6 Million CNY | 0.0% |
| 2017 FY | 746 Million CNY | 12333.33% |
| 2017 Q4 | 746 Million CNY | 12333.33% |
| 2017 Q3 | 6 Million CNY | 0.0% |
| 2017 Q1 | 6 Million CNY | 0.0% |
| 2016 Q4 | 6 Million CNY | 0.0% |
| 2016 Q1 | - CNY | 0.0% |
| 2016 Q2 | - CNY | 0.0% |
| 2016 FY | 6 Million CNY | 0.0% |
| 2016 Q3 | 6 Million CNY | 0.0% |
| 2015 Q3 | - CNY | 0.0% |
| 2015 FY | - CNY | 0.0% |
| 2015 Q1 | - CNY | 0.0% |
| 2015 Q4 | - CNY | 0.0% |
| 2015 Q2 | - CNY | 0.0% |
| 2014 Q1 | - CNY | 0.0% |
| 2014 FY | - CNY | 0.0% |
| 2014 Q4 | - CNY | 0.0% |
| 2014 Q3 | - CNY | 0.0% |
| 2014 Q2 | - CNY | 0.0% |
| 2013 FY | - CNY | 0.0% |
| 2013 Q2 | - CNY | 0.0% |
| 2013 Q3 | - CNY | 0.0% |
| 2013 Q1 | - CNY | 0.0% |
| 2013 Q4 | - CNY | 0.0% |
| 2012 Q3 | - CNY | 0.0% |
| 2012 Q1 | - CNY | 0.0% |
| 2012 Q2 | - CNY | 0.0% |
| 2012 Q4 | - CNY | 0.0% |
| 2012 FY | - CNY | 0.0% |
| 2011 Q3 | - CNY | 0.0% |
| 2011 FY | - CNY | 0.0% |
| 2011 Q4 | - CNY | 0.0% |
| 2011 Q1 | - CNY | 0.0% |
| 2011 Q2 | - CNY | 0.0% |
| 2010 FY | - CNY | 0.0% |
| 2010 Q4 | - CNY | 0.0% |
| 2010 Q3 | - CNY | -100.0% |
| 2010 Q2 | 13 Million CNY | 0.0% |
| 2009 FY | - CNY | 0.0% |
| 2009 Q4 | - CNY | 0.0% |
| 2008 FY | - CNY | 0.0% |
| 2007 FY | - CNY | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Yixintang Pharmaceutical Group Co., Ltd. | 1.55 Billion CNY | 88.665% |
| ZJAMP Group Co., Ltd. | 390.5 Million CNY | 54.944% |
| Luyan Pharma Co.,Ltd. | 652.95 Million CNY | 73.054% |
| Ji Yao Holding Group Co., Ltd. | 676.64 Million CNY | 73.997% |